UChicago 6th Annual Updates from ASH 2020: Practice Changing Abstracts
ASH Updates on R/R MM: How to Choose Amongst Available Regimens at 1st Relapse? What Is the Current Non-Cellular Therapy Landscape for Triple Refractory Disease?
Login to view comments.
Click here to Login